Diffuse Alveolar Hemorrhage With Avelumab Maintenance Therapy.
acute hypoxemic respiratory failure
diffuse alveolar hemorrage
ground-glass opacity
immune check-point inhibitor
urothelial malignancy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
accepted:
21
06
2021
entrez:
26
7
2021
pubmed:
27
7
2021
medline:
27
7
2021
Statut:
epublish
Résumé
Immune checkpoint blockade is a rapidly expanding therapeutic modality in oncology. However, its adverse effects extend beyond the cytotoxicity of conventional chemotherapy. Pneumotoxicity associated with immune checkpoint therapy presents a diagnostic conundrum that has been further complicated by the COVID-19 pandemic. We report a case of a patient with metastatic urothelial carcinoma who developed diffuse alveolar hemorrhage (DAH) following treatment with avelumab.
Identifiants
pubmed: 34306873
doi: 10.7759/cureus.15805
pmc: PMC8294017
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e15805Informations de copyright
Copyright © 2021, Li et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Thorac Cancer. 2018 Nov;9(11):1522-1524
pubmed: 30253076
Cancer Immunol Immunother. 2017 May;66(5):551-564
pubmed: 28213726
Onco Targets Ther. 2018 Sep 17;11:5879-5883
pubmed: 30271171
Case Rep Oncol. 2020 Jun 22;13(2):696-701
pubmed: 32774259
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Curr Probl Diagn Radiol. 2014 May-Jun;43(3):128-39
pubmed: 24791616
Lung Cancer. 2018 Aug;122:22-24
pubmed: 30032835
N Engl J Med. 2020 Sep 24;383(13):1218-1230
pubmed: 32945632
Ann Oncol. 2017 Mar 1;28(3):583-589
pubmed: 27998967
N Engl J Med. 2018 Jan 11;378(2):158-168
pubmed: 29320654
Respir Med Case Rep. 2020 Jun 11;30:101131
pubmed: 32577370
Cancer. 2018 May 1;124(9):2010-2017
pubmed: 29469949
Immunol Allergy Clin North Am. 2012 Nov;32(4):587-600
pubmed: 23102067
Chest. 2010 May;137(5):1164-71
pubmed: 20442117
N Engl J Med. 2016 Nov 03;375(18):1749-1755
pubmed: 27806233
Lancet Oncol. 2017 May;18(5):587-598
pubmed: 28373007
J Clin Oncol. 2017 Mar;35(7):785-792
pubmed: 28068177
Am J Respir Crit Care Med. 1995 Jan;151(1):157-63
pubmed: 7812547